Clinical Trial Update: Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

View source ↗

Summary

This document reports an update on a clinical trial comparing stem cell transplantation with non-transplant therapies for patients with high-risk myelofibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: University Health Network, Toronto | Conditions: Myelofibrosis, High-Risk Cancer | Status: ACTIVE_NOT_RECRUITING